Cas:412925-58-7 3-amino-3-(3,5-dimethoxyphenyl)propanoic acid manufacturer & supplier

We serve Chemical Name:3-amino-3-(3,5-dimethoxyphenyl)propanoic acid CAS:412925-58-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-amino-3-(3,5-dimethoxyphenyl)propanoic acid

Chemical Name:3-amino-3-(3,5-dimethoxyphenyl)propanoic acid
CAS.NO:412925-58-7
Synonyms:bb_sc-6339
Molecular Formula:C11H15NO4
Molecular Weight:225.24100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:81.78000
Exact Mass:225.10000
LogP:1.87860

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like bb_sc-6339 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bb_sc-6339 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,bb_sc-6339 Use and application,bb_sc-6339 technical grade,usp/ep/jp grade.


Related News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge. ethyl N-[1,3-dimethyl-4-(methylamino)-2,6-dioxopyrimidin-5-yl]-N-(ethoxycarbonylamino)carbamate manufacturers Throughout the pandemic, our site remained fully operational while keeping our employees safe and having a positive impact on human health. Our expanded facility will provide us with the increased capacity needed to continue the essential services we provide to our clients” 4-(dimethoxymethyl)benzyl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate suppliers Both were randomised, double-blinded, placebo-controlled trials in patients with moderate to severe autoantibody-positive SLE who were receiving standard therapy. Ethenol, 1-chloro-, benzoate vendor & factory.